Introduction
Solanezumab
CAT#10-101-180 CAS No.955085-14-0 DescriptionSolanezumab is a humanized monoclonal IgG1 antibody which is directed against the mid-domain of the Aβ peptide. By sequestering Aβ, shifting equilibria between different species of Aβ, and removing small soluble species of Aβ that are directly toxic to synaptic function, it may exert benefit. Molecular FormulaC6396H9922N1712O1996S42 M.W/Mr.144000.1g/mol Labeling TargetAmyloid precursor protein (APP) ApplicationSolanezumab, or sola, binds the amyloid-β peptides that aggregate and form plaques in the brain that are an early pathological feature of Alzheimer's disease.
Areas of Interest: Neurological Disease
Disease: Alzheimer's disease
CAT#10-101-180 CAS No.955085-14-0 DescriptionSolanezumab is a humanized monoclonal IgG1 antibody which is directed against the mid-domain of the Aβ peptide. By sequestering Aβ, shifting equilibria between different species of Aβ, and removing small soluble species of Aβ that are directly toxic to synaptic function, it may exert benefit. Molecular FormulaC6396H9922N1712O1996S42 M.W/Mr.144000.1g/mol Labeling TargetAmyloid precursor protein (APP) ApplicationSolanezumab, or sola, binds the amyloid-β peptides that aggregate and form plaques in the brain that are an early pathological feature of Alzheimer's disease.
Areas of Interest: Neurological Disease
Disease: Alzheimer's disease
Contact Info
Address:
45-16 Ramsey Road, Shirley, NY 11967, USA
Shirley, NY
NY 11967
United States
Shirley, NY
NY 11967
United States
Tel:
Website:
https://www.creative-peptides.com/product/solanezumab-item-10-101-180-33665.html
Hours of operation
| From | To | From | To | From | To | ||
|---|---|---|---|---|---|---|---|
| Monday | Open | ||||||
| Tuesday | Open | ||||||
| Wednesday | Open | ||||||
| Thursday | Open | ||||||
| Friday | Open | ||||||
| Saturday | Open | ||||||
| Sunday | Open | ||||||

